ALNY vs GNSS · P/E 76, rev $1.29B vs rev $39.9M
Alnylam Pharmaceuticals Inc (ALNY) versus Genasys Inc (GNSS) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Genasys Inc (GNSS) is a scientific & technical instruments company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported GNSS revenue for 2026-06-30 was $39.9M. Net income was -$4.8M. Revenue was up 22.4% from 2026-03-31 to 2026-06-30. GNSS currently screens at market cap $76.3M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. GNSS currently screens at market cap $76.3M.
Not investment advice. Open the ALNY and GNSS stock pages for the full models.
Not investment advice.